Our goal is to build and operate effective laboratories in-country, and develop the tools and technologies needed to collect and disseminate information generated from labs in order for stakeholders to appropriately respond to public health events.

In each of country of operation, we create laboratory systems to work in conjunction with surveillance tools to classify and confirm potential health threats. Learn more about our laboratory & diagnostic facilities' services.

Objectives:

• Design and partner in public health laboratory research conducted in internationally-certified, eHealth Africa-supported laboratories.

• Increase access to timely and quality diagnostic services for providers of maternal and child health services.

• Develop and implement a sustainable public health laboratory business model to ensure continuous operations.

Following an assessment completed early in 2020, In May 2020, eHealth Africa was awarded a contract by the CDC Foundation to implement recommended upgrades to ICT, power, and data systems at the NRL and NCDC. The scope of work was viewed as critical to ensure that NCDC and its staff would be able to store, manage, access, and analyze MBA data as part of its integrated National Serosurveillance in Nigeria project. Learn more about Integrated National Serosurveillance in Nigeria.

The HemeChip device is a point-of-care device developed by Case Western Reserve University and HemexHealth Inc. for diagnosis of sickle cell disease.

We are focused on the clinical trial of this device as well as comparing the results generated against gold-standard (high-performance liquid chromatography). Learn more about the Kano Lab and read the HemeChip case study.

eHealth Africa constructed a modular biosafety level 2 (BSL 2) laboratory for conducting a variety of tests on cerebrospinal fluid (CSF) and blood samples collected from suspected meningitis patients. Learn more about our Sokoto Meningitis Laboratory.

We continue to support Liberia’s Ministry of Health in strengthening the capacity of laboratory and diagnostic systems. This support improves timely reporting of collected specimens throughout the lab system.

With the absence of new Ebola cases in Liberia, we support the development of new diagnostic reporting systems in the labs, which produce data regarding cases of a variety of infectious diseases beyond Ebola. Learn more about Laboratory Support in Liberia.